Genetic markers of type 2 diabetes: Progress in genome-wide association studies and clinical application for risk prediction

Journal of Diabetes

Volumn 8, Issue 1, 2016, Pages 24-35

  Wang, Xueyin ^a,b   Strizich, Garrett ^a   Hu, Yonghua ^b   Wang, Tao ^a   Kaplan, Robert C ^a   Qi, Qibin ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Area under the receiver operating characteristic curve; Genetics; Genome wide association studies; Type 2 diabetes

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; HEPATOCYTE NUCLEAR FACTOR 1BETA; LEPTIN; NOTCH2 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POTASSIUM CHANNEL KCNQ1; PROTEIN BCL 2; TRANSCRIPTION FACTOR 7 LIKE 2; GENETIC MARKER;

ADAMTS9 GENE; ADCY5 GENE; ALX4 GENE; ANKRD55 GENE; AP3S2 GENE; ARAP1 GENE; ARL15 GENE; BCL11A GENE; BCL2 GENE; C2CD4A GENE; C2CD4B GENE; CDC123 GENE; CDKAL1 GENE; CDKN2A GENE; CDKN2B GENE; CENTD2 GENE; CILP2 GENE; DGKB GENE; DISEASE PREDISPOSITION; DUSP9 GENE; EXT2 GENE; FAF1 GENE; FITM2 GENE; FTO GENE; GATAD2A GENE; GCC1 GENE; GCK GENE; GCKR GENE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLIS3 GENE; GPSM1 GENE; GRB14 GENE; GRK5 GENE; HHEX GENE; HMG20A GENE; HMGA2 GENE; HNF1A GENE; HNF1B GENE; HNF4A GENE; HUMAN; IGF2BP2 GENE; JAZF1 GENE; KCNJ11 GENE; KCNK16 GENE; KCNQ1 GENE; KIF11 GENE; KLF14 GENE; LEP GENE; LGR5 GENE; LPP GENE; MAEA GENE; MIR129 GENE; MODY5 GENE; MPHOSPH9 GENE; MTNR1B GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTCH2 GENE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PAX4 GENE; PBX4 GENE; PEPD GENE; POU5F1 GENE; PPARG GENE; PRC1 GENE; PRIORITY JOURNAL; PROX1 GENE; PSMD6 GENE; PTPRD GENE; R3HDML GENE; RASGRP1 GENE; RBM43 GENE; RBMS1 GENE; REVIEW; RND3 GENE; RREB1 GENE; SGCG GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC16A11 GENE; SLC16A13 GENE; SLC30A8 GENE; SPRY2 GENE; SRR GENE; SSR1 GENE; ST6GAL1 GENE; TCF19 GENE; TCF2 GENE; TCF7L2 GENE; THADA GENE; TLE1 GENE; TLE4 GENE; TMEM154 GENE; TMEM163 GENE; TMEM195 GENE; TP53INP1 GENE; TSPAN8 GENE; UBE2E2 GENE; VPS26A GENE; WFS1 GENE; ZBED3 GENE; ZFAND3 GENE; ZFAND6 GENE; ZMIZ1 GENE; DIABETES MELLITUS, TYPE 2; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84954027630     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12323     Document Type: Review

References (93)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94: 311-321.
2. Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD. Concordance rate for type II diabetes mellitus in monozygotic twins: Actuarial analysis. Diabetologia. 1999; 42: 146-150.
3. Li G, Zhang P, Wang J etal. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: A 20-year follow-up study. Lancet. 2008; 371: 1783-1789.
4. Lindstrom J, Ilanne-Parikka P, Peltonen M etal. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006; 368: 1673-1679.
5. Paulweber B, Valensi P, Lindstrom J etal. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res. 2010; 42 (Suppl. 1): S3-36.
6. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: Systematic review. BMJ. 2011; 343: d7163.
7. Echouffo-Tcheugui JB, Dieffenbach SD, Kengne AP. Added value of novel circulating and genetic biomarkers in type 2 diabetes prediction: A systematic review. Diabetes Res Clin Pract. 2013; 101: 255-269.
8. Buijsse B, Simmons RK, Griffin SJ, Schulze MB. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev. 2011; 33: 46-62.
9. Siddiqui K, Musambil M, Nazir N. Maturity onset diabetes of the young (MODY): History, first case reports and recent advances. Gene. 2015; 555: 66-71.
10. Altshuler D, Hirschhorn JN, Klannemark M etal. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000; 26: 76-80.
11. Gloyn AL, Weedon MN, Owen KR etal. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes. 2003; 52: 568-572.
12. Grant SF, Thorleifsson G, Reynisdottir I etal. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006; 38: 320-323.
13. Sandhu MS, Weedon MN, Fawcett KA etal. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet. 2007; 39: 951-953.
14. Saxena R, Voight BF, Lyssenko V etal. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007; 316: 1331-1336.
15. Scott LJ, Mohlke KL, Bonnycastle LL etal. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007; 316: 1341-1345.
16. Zeggini E, Weedon MN, Lindgren CM etal. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007; 316: 1336-1341.
17. Franks PW, Rolandsson O, Debenham SL etal. Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia. 2008; 51: 458-463.
18. Zeggini E, Scott LJ, Saxena R etal. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008; 40: 638-645.
19. Dupuis J, Langenberg C, Prokopenko I etal. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42: 105-116.
20. Rung J, Cauchi S, Albrechtsen A etal. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet. 2009; 41: 1110-1115.
21. Qi L, Cornelis MC, Kraft P etal. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet. 2010; 19: 2706-2715.
22. Voight BF, Scott LJ, Steinthorsdottir V etal. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010; 42: 579-589.
23. Morris AP, Voight BF, Teslovich TM etal. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012; 44: 981-990.
24. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014; 46: 234-244.
25. Gudmundsson J, Sulem P, Steinthorsdottir V etal. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet. 2007; 39: 977-983.
26. Saxena R, Elbers CC, Guo Y etal. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet. 2012; 90: 410-425.
27. Yamauchi T, Hara K, Maeda S etal. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet. 2010; 42: 864-868.
28. Cho YS, Chen CH, Hu C etal. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet. 2012; 44: 67-72.
29. Ma RC, Hu C, Tam CH etal. Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia. 2013; 56: 1291-1305.
30. Hara K, Fujita H, Johnson TA etal. Genome-wide association study identifies three novel loci for type 2 diabetes. Hum Mol Genet. 2014; 23: 239-246.
31. Imamura M, Maeda S, Yamauchi T etal. A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Hum Mol Genet. 2012; 21: 3042-3049.
32. Tsai FJ, Yang CF, Chen CC etal. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet. 2010; 6: e1000847.
33. Li H, Gan W, Lu L etal. A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes. 2013; 62: 291-298.
34. Yasuda K, Miyake K, Horikawa Y etal. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet. 2008; 40: 1092-1097.
35. Shu XO, Long J, Cai Q etal. Identification of new genetic risk variants for type 2 diabetes. PLoS Genet. 2010; 6: e1001127.
36. Kooner JS, Saleheen D, Sim X etal. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011; 43: 984-989.
37. Tabassum R, Chauhan G, Dwivedi OP etal. Genome-wide association study for type 2 diabetes in Indians identifies a new susceptibility locus at 2q21. Diabetes. 2013; 62: 977-986.
38. Palmer ND, McDonough CW, Hicks PJ etal. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS ONE. 2012; 7: e29202.
39. Williams AL, Jacobs SB, Moreno-Macias H etal. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature. 2014; 506: 97-101.
40. Sladek R, Rocheleau G, Rung J etal. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445: 881-885.
41. Steinthorsdottir V, Thorleifsson G, Reynisdottir I etal. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007; 39: 770-775.
42. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14000 cases of seven common diseases and 3000 shared controls. Nature. 2007; 447: 661-678.
43. Frayling TM, Timpson NJ, Weedon MN etal. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316: 889-894.
44. Lyssenko V, Nagorny CL, Erdos MR etal. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet. 2009; 41: 82-88.
45. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C etal. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet. 2009; 41: 89-94.
46. Unoki H, Takahashi A, Kawaguchi T etal. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet. 2008; 40: 1098-1102.
47. Holt LJ, Lyons RJ, Ryan AS etal. Dual ablation of Grb10 and Grb14 in mice reveals their combined role in regulation of insulin signaling and glucose homeostasis. Mol Endocrinol. 2009; 23: 1406-1414.
48. Saxena R, Saleheen D, Been LF etal. Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India. Diabetes. 2013; 62: 1746-1755.
49. Savage DB, Semple RK. Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance. Curr Opin Lipidol. 2010; 21: 329-336.
50. Samuel VT, Shulman GI. Mechanisms for insulin resistance: Common threads and missing links. Cell. 2012; 148: 852-871.
51. Hara K, Shojima N, Hosoe J, Kadowaki T. Genetic architecture of type 2 diabetes. Biochem Biophys Res Commun. 2014; 452: 213-220.
52. Weedon MN, McCarthy MI, Hitman G etal. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 2006; 3: e374.
53. Janssens AC, Gwinn M, Khoury MJ, Subramonia-Iyer S. Does genetic testing really improve the prediction of future type 2 diabetes? PLoS Med. 2006; 3: e114.
54. Vaxillaire M, Veslot J, Dina C etal. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes. 2008; 57: 244-254.
55. Balkau B, Lange C, Fezeu L etal. Predicting diabetes: Clinical, biological, and genetic approaches: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care. 2008; 31: 2056-2061.
56. Xu M, Bi Y, Xu Y etal. Combined effects of 19 common variations on type 2 diabetes in Chinese: Results from two community-based studies. PLoS ONE. 2010; 5: e14022.
57. Tam CH, Ho JS, Wang Y etal. Use of net reclassification improvement (NRI) method confirms the utility of combined genetic risk score to predict type 2 diabetes. PLoS ONE. 2013; 8: e83093.
58. Shigemizu D, Abe T, Morizono T etal. The construction of risk prediction models using GWAS data and its application to a type 2 diabetes prospective cohort. PLoS ONE. 2014; 9: e92549.
59. Cornelis MC, Qi L, Zhang C etal. Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Ann Intern Med. 2009; 150: 541-550.
60. Lyssenko V, Jonsson A, Almgren P etal. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008; 359: 2220-2232.
61. Miyake K, Yang W, Hara K etal. Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association. J Hum Genet. 2009; 54: 236-241.
62. Cauchi S, Ezzidi I, El Achhab Y etal. European genetic variants associated with type 2 diabetes in North African Arabs. Diabetes Metab. 2012; 38: 316-323.
63. Cauchi S, Meyre D, Durand E etal. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS ONE. 2008; 3: e2031.
64. Lin X, Song K, Lim N etal. Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score: The CoLaus Study. Diabetologia. 2009; 52: 600-608.
65. Fontaine-Bisson B, Renstrom F, Rolandsson O etal. Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population. Diabetologia. 2010; 53: 2155-2162.
66. Qi Q, Li H, Wu Y etal. Combined effects of 17 common genetic variants on type 2 diabetes risk in a Han Chinese population. Diabetologia. 2010; 53: 2163-2166.
67. Meigs JB, Shrader P, Sullivan LM etal. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008; 359: 2208-2219.
68. van Hoek M, Dehghan A, Witteman JC etal. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: A population-based study. Diabetes. 2008; 57: 3122-3128.
69. Lango H, Palmer CN, Morris AD etal. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes. 2008; 57: 3129-3135.
70. Hu C, Zhang R, Wang C etal. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS ONE. 2009; 4: e7643.
71. Sparso T, Grarup N, Andreasen C etal. Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interaction. Diabetologia. 2009; 52: 1308-1314.
72. Wang J, Stancakova A, Kuusisto J, Laakso M. Identification of undiagnosed type 2 diabetic individuals by the Finnish diabetes risk score and biochemical and genetic markers: A population-based study of 7232 Finnish men. J Clin Endocrinol Metab. 2010; 95: 3858-3862.
73. Schulze MB, Weikert C, Pischon T etal. Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: The EPIC-Potsdam Study. Diabetes Care. 2009; 32: 2116-2119.
74. Talmud PJ, Hingorani AD, Cooper JA etal. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ. 2010; 340: b4838.
75. Raynor LA, Pankow JS, Duncan BB etal. Novel risk factors and the prediction of type 2 diabetes in the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2013; 36: 70-76.
76. Janipalli CS, Kumar MV, Vinay DG etal. Analysis of 32 common susceptibility genetic variants and their combined effect in predicting risk of Type 2 diabetes and related traits in Indians. Diabet Med. 2012; 29: 121-127.
77. Hivert MF, Jablonski KA, Perreault L etal. Updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes. 2011; 60: 1340-1348.
78. Ruchat SM, Vohl MC, Weisnagel SJ, Rankinen T, Bouchard C, Perusse L. Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism. Ann Med. 2010; 42: 196-206.
79. Vassy JL, Durant NH, Kabagambe EK etal. A genotype risk score predicts type 2 diabetes from young adulthood: The CARDIA study. Diabetologia. 2012; 55: 2604-2612.
80. Schmid R, Vollenweider P, Bastardot F, Vaucher J, Waeber G, Marques-Vidal P. Current genetic data do not improve the prediction of type 2 diabetes mellitus: The CoLaus study. J Clin Endocrinol Metab. 2012; 97: E1338-1341.
81. de Miguel-Yanes JM, Shrader P, Pencina MJ etal. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care. 2011; 34: 121-125.
82. Muhlenbruch K, Jeppesen C, Joost HG, Boeing H, Schulze MB. The value of genetic information for diabetes risk prediction: Differences according to sex, age, family history and obesity. PLoS ONE. 2013; 8: e64307.
83. Kwak SH, Choi SH, Kim K etal. Prediction of type 2 diabetes in women with a history of gestational diabetes using a genetic risk score. Diabetologia. 2013; 56: 2556-2563.
84. Imamura M, Shigemizu D, Tsunoda T etal. Assessing the clinical utility of a genetic risk score constructed using 49 susceptibility alleles for type 2 diabetes in a Japanese population. J Clin Endocrinol Metab. 2013; 98: E1667-1673.
85. Walford GA, Porneala BC, Dauriz M etal. Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. Diabetes Care. 2014; 37: 2508-2514.
86. Vaxillaire M, Yengo L, Lobbens S etal. Type 2 diabetes-related genetic risk scores associated with variations in fasting plasma glucose and development of impaired glucose homeostasis in the prospective DESIR study. Diabetologia. 2014; 57: 1601-1610.
87. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med. 2008; 27: 157-172.
88. Janssens AC, Khoury MJ. Assessment of improved prediction beyond traditional risk factors: When does a difference make a difference? Circ Cardiovas Genet. 2010; 3: 3-5.
89. Mihaescu R, van Zitteren M, van Hoek M etal. Improvement of risk prediction by genomic profiling: Reclassification measures versus the area under the receiver operating characteristic curve. Am J Epidemiol. 2010; 172: 353-361.
90. Bao W, Hu FB, Rong S etal. Predicting risk of type 2 diabetes mellitus with genetic risk models on the basis of established genome-wide association markers: A systematic review. Am J Epidemiol. 2013; 178: 1197-1207.
91. Pencina MJ, D'Agostino RB Sr, Demler OV. Novel metrics for evaluating improvement in discrimination: Net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med. 2012; 31: 101-113.
92. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011; 30: 11-21.
93. Ware JH, Cai T. Comments on "Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond" by M. J. Pencina etal., Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med. 2008; 27: 185-187.